151 related articles for article (PubMed ID: 14962242)
1. Successful treatment of oral lesions of chronic lichenoid graft-vs.-host disease by the addition of low-level laser therapy to systemic immunosuppression.
Chor A; de Azevedo AM; Maiolino A; Nucci M
Eur J Haematol; 2004 Mar; 72(3):222-4. PubMed ID: 14962242
[TBL] [Abstract][Full Text] [Related]
2. Prospects for ultraviolet A1 phototherapy as a treatment for chronic cutaneous graft-versus-host disease.
Calzavara Pinton P; Porta F; Izzi T; Venturini M; Capezzera R; Zane C; Notarangelo LD
Haematologica; 2003 Oct; 88(10):1169-75. PubMed ID: 14555314
[TBL] [Abstract][Full Text] [Related]
3. Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin.
Wetzig T; Sticherling M; Simon JC; Hegenbart U; Niederwieser D; Al-Ali HK
Bone Marrow Transplant; 2005 Mar; 35(5):515-9. PubMed ID: 15665847
[TBL] [Abstract][Full Text] [Related]
4. [Cutaneous graft versus host disease].
Aractingi S; Chosidow O; Gluckman E; Socié G
Presse Med; 1995 Apr; 24(14):679-85. PubMed ID: 7770416
[TBL] [Abstract][Full Text] [Related]
5. Acute severe form of lichenoid graft-versus-host disease after donor lymphocyte infusions.
Ruiz-Genao DP; F-Peñas P; Daudén E; García-F-Villalta MJ; Fraga J; García-Diez A
J Eur Acad Dermatol Venereol; 2006 May; 20(5):632-4. PubMed ID: 16684312
[No Abstract] [Full Text] [Related]
6. The effect of budesonide mouthwash on oral chronic graft versus host disease.
Sari I; Altuntas F; Kocyigit I; Sisman Y; Eser B; Unal A; Fen T; Ferahbas A; Ozturk A; Unal A; Cetin M
Am J Hematol; 2007 May; 82(5):349-56. PubMed ID: 17109390
[TBL] [Abstract][Full Text] [Related]
7. Superficial mucoceles in chronic graft-versus-host disease: a case report and review of the literature.
Balasubramaniam R; Alawi F; DeRossi S
Gen Dent; 2009; 57(1):82-8. PubMed ID: 19146147
[TBL] [Abstract][Full Text] [Related]
8. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus.
Eckardt A; Starke O; Stadler M; Reuter C; Hertenstein B
Oral Oncol; 2004 Sep; 40(8):811-4. PubMed ID: 15288836
[TBL] [Abstract][Full Text] [Related]
9. CO2 laser in oral graft-versus-host disease: a pilot study.
Elad S; Or R; Shapira MY; Haviv A; Galili D; Garfunkel AA; Bitan M; Kaufman E
Bone Marrow Transplant; 2003 Nov; 32(10):1031-4. PubMed ID: 14595392
[TBL] [Abstract][Full Text] [Related]
10. Impact of chronic allograft nephropathy and subsequent modifications of immunosuppressive therapy on late graft outcomes in renal transplantation.
Montagnino G; Banfi G; Campise MR; Passerini P; Aroldi A; Cesana BM; Ponticelli C
Nephrol Dial Transplant; 2004 Oct; 19(10):2622-9. PubMed ID: 15316096
[TBL] [Abstract][Full Text] [Related]
11. Is there an effective therapy for chronic graft-versus-host disease?
Schiller G; Gale RP
Bone Marrow Transplant; 1993 Mar; 11(3):189-92. PubMed ID: 8467281
[No Abstract] [Full Text] [Related]
12. The irreplaceable image: Amelioration of oral mucosal lesions of acute graft-versus-host disease by low-level laser therapy.
Chor A; Sotero Caio AB; de Azevedo AM
Haematologica; 2001 Dec; 86(12):1321. PubMed ID: 11726330
[No Abstract] [Full Text] [Related]
13. Systemic FK506 improved tear secretion in dry eye associated with chronic graft versus host disease.
Aoki S; Mizote H; Minamoto A; Suzuki M; Mishima HK; Tanaka H
Br J Ophthalmol; 2005 Feb; 89(2):243-4. PubMed ID: 15665364
[No Abstract] [Full Text] [Related]
14. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
[TBL] [Abstract][Full Text] [Related]
15. Management of oral pain in patients with malignant diseases.
Barasch A; Safford MM
Compendium; 1993 Nov; 14(11):1376, 1378-82, 1384; quiz 1386. PubMed ID: 8620375
[TBL] [Abstract][Full Text] [Related]
16. Follicular graft-versus-host disease: a rare manifestation of chronic cutaneous graft-versus-host disease.
Martí N; Martin JM; Monteagudo C; López V; Jordá E
Am J Dermatopathol; 2008 Dec; 30(6):620-1. PubMed ID: 19033942
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal chronic graft-versus-host disease: management options.
Awan F; Hamadani M
J Oncol Pharm Pract; 2007 Mar; 13(1):49-51. PubMed ID: 17621568
[TBL] [Abstract][Full Text] [Related]
18. Detection of human papillomavirus in multiple eccrine poromas in a patient with chronic graft-vs-host disease and immunosuppression.
Diamantis ML; Richmond HM; Rady PL; Tyring SK; Cutlan JE; Torres-Cabala C; Hymes SR
Arch Dermatol; 2011 Jan; 147(1):120-2. PubMed ID: 21242407
[No Abstract] [Full Text] [Related]
19. Acute graft-versus-host disease after liver transplant: novel use of etanercept and the role of tumor necrosis factor alpha inhibitors.
Thin L; Macquillan G; Adams L; Garas G; Seow C; Cannell P; Augustson B; Mitchell A; Delriveire L; Jeffrey G
Liver Transpl; 2009 Apr; 15(4):421-6. PubMed ID: 19326415
[TBL] [Abstract][Full Text] [Related]
20. Update on extracorporeal photochemotherapy for graft-versus-host disease treatment.
Kanold J; Messina C; Halle P; Locatelli F; Lanino E; Cesaro S; Deméocq F;
Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S69-71. PubMed ID: 15812535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
